| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On December 4, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket
#
|
| Title
|
|
|
|
|
|
|
| 1995N-0362
|
| CGMP Certain Requirements for Finished Pharmaceuticals
|
|
|
|
|
| 2005P-0450
|
| Revoke the GRAS Status of Salt, Set Ceilings on the Amount of Sodium in Processed Foods, Require a Health Warning on Packaged Salt, and Reduce the Daily Value for Sodium
|
|
|
|
|
| 2006D-0347
|
| Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
|
|
|
|
|
| 2006N-0168
|
| Food Labeling: Reference Daily Intakes & Daily Reference Values
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| 2007F-0454
|
| General Mills, Inc.; Filing of Food Additive Petition
|
|
|
|
|
| 2007N-0280
|
| Amendment to the CGMP Regulations for Finished Pharmaceuticals
|
|
|
|
|
| 2007N-0343
|
| Electronic Nonclinical Study Data Submission; Notice of Pilot Project
|
|
|
|
|
| 2007N-0348
|
| Establishing a Docket for the Development of Safety and Effectiveness Assessments of Vaccines Used for Pandemic Influenza
|
|
|
|
|
| 2007N-0356
|
| BEHIND THE COUNTER AVAILABILITY OF CERTAIN DRUGS; Public Meeting
|
|
|
|
|
| 2007N-0453
|
| DSM Nutritional Products, Inc.; Filing of Color Additive Petition
|
|
|
|
|
| 2007P-0085
|
| Adopt Regulations of General Applicability to all Food Standards that would Permit Deviations from the Requirements of the Individual Food Standards of Identity
|
|
|
|
|
| 2007P-0224
|
| Take special consideration when reviewing amy application for a generic version of AMBIEN CR (zolpidem tartrate extended-release tablets)
|
|
|
|
|
| 2007P-0251
|
| Petition for a policy statement requiring that all future advisory committee meetings discussing specific products include an oral scientific presentation by FDA staff on the products reviewed, includ
|
|
|
|
|
|
|
|
|
| 2007P-0438
|
| Declare Angel Parfum, Angel Eau du Toilette and other Angel related fragranced products be declared misbranded and have their importation ceased until their safety can be independently verified
|
|
|
|
|
| 2007P-0470
|
| Administrative action regarding CLOMID (clomiphene citrate), NDA 16-131 and its generics
|
|
| |
|
| 1995N-0362
|
| CGMP Certain Requirements for Finished Pharmaceuticals
|
|
|
|
|
| NWL 1
|
| FDA
|
| Vol #:
|
| 5
|
|
|
|
|
| 2005P-0450
|
| Revoke the GRAS Status of Salt, Set Ceilings on the Amount of Sodium in Processed Foods, Require a Health Warning on Packaged Salt, and Reduce the Daily Value for Sodium
|
|
|
|
|
| EC 14
|
| Wageningen University
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 15
|
| Ms. Elizabeth Dufraine
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 16
|
| Mr. Robert Perou
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 17
|
| Mrs. Karen Lucas
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 18
|
| Mrs. yolanda steward
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 19
|
| Mr. Douglas Kolozsvari
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 20
|
| Mr. Matthew Conlon
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 21
|
| Mr. Stephen Hart
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 22
|
| Radboud University Nijmeren Medical Centre
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 23
|
| Menzies Research Institute
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 24
|
| Georgian Society of Hypertension
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 25
|
| Federico II Univ of Naples, Dept.Clin. Exp. Med.
|
| Vol #:
|
| 1
|
|
| |
|
| 2006D-0347
|
| Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
|
|
|
|
|
| C 25
|
| National Venture Capital Associaton
|
| Vol #:
|
| 3
|
|
| | | | | | | | |
|
| |
|
| 2006N-0168
|
| Food Labeling: Reference Daily Intakes & Daily Reference Values
|
|
|
|
|
| EC 105
|
| Mr. Michael Jones
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| C 491
|
| M. Athinson
|
| Vol #:
|
| 14
|
|
| |
|
| 2007F-0454
|
| General Mills, Inc.; Filing of Food Additive Petition
|
|
|
|
|
| NFL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0280
|
| Amendment to the CGMP Regulations for Finished Pharmaceuticals
|
|
|
|
|
| NFR 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| NPR 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0343
|
| Electronic Nonclinical Study Data Submission; Notice of Pilot Project
|
|
|
|
|
| EC 2
|
| Merck Research Laboratories
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0348
|
| Establishing a Docket for the Development of Safety and Effectiveness Assessments of Vaccines Used for Pandemic Influenza
|
|
|
|
|
| EC 1
|
| GlaxoSmithKline
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 2
|
| Sanofi Pasteur
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 3
|
| MedImmune, Inc.
|
| Vol #:
|
| 1
|
|
| |
|
| 2007N-0356
|
| BEHIND THE COUNTER AVAILABILITY OF CERTAIN DRUGS; Public Meeting
|
|
|
|
|
| EC 112
|
| Asthma and Allergy Foundation of America
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 113
|
| Mr. Neil Abrahams
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 114
|
| National Community Pharmacists Association
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 115
|
| Dr. Geeta Khare
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 116
|
| Center for Consumer Self Care,UCSF Sch.of Pharmacy
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 117
|
| American Association of Clinical Endocrinologists
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 118
|
| National Alliance of State Pharmacy Associations
|
| Vol #:
|
| 2
|
|
|
|
|
| 2007N-0453
|
| DSM Nutritional Products, Inc.; Filing of Color Additive Petition
|
|
|
|
|
| NFL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
| |
|
| 2007P-0085
|
| Adopt Regulations of General Applicability to all Food Standards that would Permit Deviations from the Requirements of the Individual Food Standards of Identity
|
|
|
|
|
| C 359
|
| L. Gibbons
|
| Vol #:
|
| 102
|
|
|
|
|
| 2007P-0224
|
| Take special consideration when reviewing amy application for a generic version of AMBIEN CR (zolpidem tartrate extended-release tablets)
|
|
|
|
|
| LET 1
|
| Jane A. Axelrad
|
| Vol #:
|
| 2
|
|
|
|
|
| 2007P-0251
|
| Petition for a policy statement requiring that all future advisory committee meetings discussing specific products include an oral scientific presentation by FDA staff on the products reviewed, includ
|
|
|
|
|
|
|
|
